Atlas Trials

Clinical Study Assessing the Safety, Tolerability, and Pharmacokinetics of Intravenous AZD5099 in Healthy Subjects

Clinical trial NCT01340183 · SUSPENDED

Trial details

NCT number
NCT01340183
Sponsor
AstraZeneca
Status
SUSPENDED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2011-05-01
Primary completion
2011-12-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.